ENBUMYST Trademark

Trademark Overview


On Sunday, September 21, 2025, a trademark application was filed for ENBUMYST with the United States Patent and Trademark Office. The USPTO has given the ENBUMYST trademark a serial number of 99404639. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, March 6, 2026. This trademark is owned by Corstasis Therapeutics, Inc.. The ENBUMYST trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical apparatus and instruments in the nature of a delivery device for nasal spray for use in delivering cardiovascular pharmaceuticals via nasal spray procedures

Cardiovascular agents for medical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medical apparatus and instruments in the nature of nasal sprays for use in delivering cardiovascular pharmaceuticals via nasal spray procedures; Medical apparatus and instruments in the nature of nasal sprays for treating cardiovascular disease
enbumyst

General Information


Serial Number99404639
Word MarkENBUMYST
Filing DateSunday, September 21, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, March 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "ENBUMYST" with six partial circles of dots to the right of the word and arching counterclockwise over the "T" and ending at the top of the "S".
Goods and ServicesMedical apparatus and instruments in the nature of a delivery device for nasal spray for use in delivering cardiovascular pharmaceuticals via nasal spray procedures
Goods and ServicesCardiovascular agents for medical purposes; Cardiovascular pharmaceutical preparations; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medical apparatus and instruments in the nature of nasal sprays for use in delivering cardiovascular pharmaceuticals via nasal spray procedures; Medical apparatus and instruments in the nature of nasal sprays for treating cardiovascular disease
Pseudo MarkENBU MIST

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, September 21, 2025
Primary Code005
First Use Anywhere DateMonday, December 9, 2024
First Use In Commerce DateTuesday, August 5, 2025

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, September 21, 2025
Primary Code010
First Use Anywhere DateMonday, December 9, 2024
First Use In Commerce DateTuesday, August 5, 2025

Trademark Owner History


Party NameCorstasis Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHenderson, NV 89052
US

Trademark Events


Event DateEvent Description
Sunday, September 21, 2025NEW APPLICATION ENTERED
Sunday, September 21, 2025APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 12, 2026NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 13, 2026ASSIGNED TO EXAMINER
Thursday, February 26, 2026NON-FINAL ACTION WRITTEN
Thursday, February 26, 2026NON-FINAL ACTION E-MAILED
Thursday, February 26, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 5, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 5, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 6, 2026TEAS/EMAIL CORRESPONDENCE ENTERED